Sodium Hydroxide → Atrinositol

HRID 232391

反応式

HRID 232391 の反応式
[CH:1]1([O:32][P:33]([O-:36])([O-:35])=[O:34])[CH:6]([O:7][P:8]([O-:11])([O-:10])=[O:9])[CH:5]([O:12][P:13]([O-:16])([O-:15])=[O:14])[CH:4]([O:17]P([O-])([O-])=O)[CH:3]([O:22]P([O-])([O-])=O)[CH:2]1[O:27]P([O-])([O-])=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[OH-].[Na+]>C(O)C>[C@H:4]1([OH:17])[CH:3]([OH:22])[C@@H:2]([OH:27])[C@@H:1]([O:32][P:33]([OH:36])([OH:35])=[O:34])[CH:6]([O:7][P:8]([OH:10])([OH:11])=[O:9])[C@@H:5]1[O:12][P:13]([OH:15])([OH:16])=[O:14]

参加物

4

実験手順

100 ml of the fraction containing D-myo-inositol-1.2.6-triphosphate obtained in Example 15 was neutralized to a pH of about 7 with an aqueous solution of NaOH. After addition of 100 ml ethanol the volume of the solution was reduced by evaporation and the sodiumsalt was precipitated, centrifuged, recrystallized and dried in vacuum. The purified sodiumsalt of D-myo-inositol-1.2.6-triphosphate obtained was structurally confirmed by analysis with H-NMR.

後処理

  1. customwas reduced by evaporation
  2. customthe sodiumsalt was precipitated
  3. customrecrystallized
  4. customdried in vacuum

出典と根拠

ORDレコード
ord-bc91b0ea600744548cec0081e6df62c8
出典データセット
uspto-grants-1989_07
特許番号
US04851560

関連ノート

読み込み中…